Asensus Surgical, Inc. (ASXC)
Aug 22, 2024 - ASXC was delisted (reason: acquired by KARL STORZ)
0.350
0.00 (0.00%)
Inactive · Last trade price
on Aug 21, 2024
Asensus Surgical Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Asensus Surgical stock has a target of 0.35, which predicts no change from the current stock price of 0.35.
Analyst Consensus: Hold
* Price targets were last updated on May 16, 2024.
Analyst Ratings
The average analyst rating for ASXC stock from 2 stock analysts was "Hold". This means that analysts believed this stock was likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 | Aug '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $0.35 | Hold | Reiterates | $0.35 | n/a | May 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $2 → $0.35 | Strong Buy → Hold | Downgrades | $2 → $0.35 | n/a | Apr 4, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $2 | Strong Buy | Maintains | $2 | +471.43% | Mar 22, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Nov 16, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $2 | Strong Buy | Reiterates | $2 | +471.43% | Nov 15, 2023 |
Financial Forecast
Revenue This Year
12.30M
from 8.58M
Increased by 43.43%
Revenue Next Year
22.35M
from 12.30M
Increased by 81.68%
EPS This Year
-0.24
from -0.31
EPS Next Year
-0.19
from -0.24
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 15.0M | 33.1M | 54.0M | ||
| Avg | 12.3M | 22.4M | 52.4M | ||
| Low | 9.6M | 12.1M | 50.4M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 75.3% | 169.1% | 141.4% | ||
| Avg | 43.4% | 81.7% | 134.5% | ||
| Low | 12.0% | -2.0% | 125.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.22 | -0.14 | -0.08 | ||
| Avg | -0.24 | -0.19 | -0.08 | ||
| Low | -0.26 | -0.25 | -0.08 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.